Articles On Neuren Pharmaceuticals (ASX:NEU)

US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Neuren Pharmaceuticals’ (ASX: NEU) NNZ-2591 for the treatment of Angelman syndrome. Orphan Drug designation is a special status that the FDA may grant to a drug to...

The S&P/ASX 200 index looks set to finish the week on a high on Friday. In afternoon trade the benchmark index is up 0.65% to 6,761.1 points. Four shares that have failed to follow the market higher today are listed below. Here’s why t...

Even though the stock markets are sensitive to the global macro-economic parameters, in the present scenario, the investors need to maintain their focus towards the US corporate earnings. The companies, generally, provide information on how...

Healthcare Healthcare sector comprises of the companies that offer medical services, producing medical equipment or medicines. These companies also give medical insurance to the patients. In Australia, the funding of healthcare is taken ca...

In the never-ending battle against bacteria, Next Science (ASX:NSX) has adopted a ‘take no prisoners’ approach in eradicating the bodily bolt holes in which these pathogens congregate and quietly multiply. With a suite of four approved prod...